Home | Anti-PD-1 2C12 in patients with Hodgkin lymphoma. HOPE 2C12 Study

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Anti-PD-1 2C12 in patients with Hodgkin lymphoma. HOPE 2C12 Study has only one revision
RevisionStatus
Saved 01/10/2026 - 11:41am by Gladys

Thanks

current revision (published)